JM Bryant, MD (@JMBryantMD) profile picture

Radiation Oncology Resident @MoffittRadOnc // Husband + Girl Dad

Joined March 2020
Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)Photo by JM Bryant, MD (@JMBryantMD)
Extremely excited and proud to have matched at Moffitt Cancer Center! Could not have done this without the support of my loving wife @katerinabryant, family, friends, and mentors! Also looking forward to training with my good friend @rcruzchamorro @MoffittRadOnc #RadOncMatch20
2
2
24
Congratulations to our Graduating Medical and Physics Residents! (Dr. Bryant, Dr. Cruz-Chamorro and Dr. Koo). We are so proud of you and know you will go onto great things! @JMBryantMD @RCruzChamorro @JessicaFrakesMD @EvanWuthrick @KOSJ12 @MoffittRadOnc @MoffittNews #radonc
2
4
35
1,981
Congratulations to our graduating chief residents for passing their clinical boards!! 🎉💯 @JMBryantMD @RCruzChamorro
2
1
18
2,235
This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.
54
487
136
1,469
482,131
This year, we received a record number of applications and interviewed an incredibly competitive group. We’re thrilled to announce our match class! #MatchDay2025 #RadOnc ⚡️☢️☀️🌊@SylvesterCancer @umiamimedicine @HenriFordMD @DrSDNimer
3
5
68
4,667
Thank you so much to Dr. Einhorn for being our honored guest at Resident Research Day ! Congrats to all the residents and their great presentations ! @MoffittRadOnc @MoffittNews @KOSJ12 @JessicaFrakesMD @JMBryantMD @RCruzChamorro #radonc
1
9
29
2,265
Patients can benefit from SBRT / PBT over TACE in HCC (ineligible for upfront surgery/transplant) ! 🚨 Local Control HR 0.16 (0.08, 0.34) 🚨 💥 PFS HR 0.37 (0.23, 0.60) 💥 OS RR 0.79 (0.51, 1.22) Toxicity RR 0.86 (0.31, 2.37)
1
10
1
29
6,013
As we enter the last week of pancreas cancer awareness month- I want to remind everyone that the status quo is NOT GOOD ENOUGH for our patients. The only way we will make any progress is to design (& fund!) patient-centered clinical trials. Here are some I'm excited about 🧵:
4
14
96
6,323
Congratulations to @Naghavi_MD, @JMBryantMD, et al. for their HARD work and creating innovative and sophisticated solutions for patients with unresected soft-tissue sarcoma! Hypofractionated accelerated radiation dose-painting (HARD) improves o... sciencedirect.com/science/ar…
1
7
18
1,430
Is preoperative SRS an option for brain metastases undergoing resection? Proud to share the INTERNEO results- an international collaboration of neoadjuvant SRS @RO_GreenJournal ↘️ low rates of local recurrence, nodular LMD and radionecrosis (all <5% at 12 months) 🌍 Global experience: nine institutions across 5 countries 🇦🇺🇺🇸🇨🇭🇯🇵🇨🇦 ⚡️⚡️⚡️High proportion multi-fraction SRS ⏱️Extended follow-up Link: authors.elsevier.com/a/1k9iP… @HaghighiNeda @PeterMacRadOnc
6
34
1
83
7,036
JM Bryant, MD retweeted
Utilizing the HARD technique for Unresected sarcomas showed a 2-fold increase in 3y LRC (96% v 48%), when compared to standard fractionated RT. Congrats to @JMBryantMD for acceptance in @RO_GreenJournal. @MoffittRadOnc @MoffittNews #greenjournal @RadiotherapyOn1 @QuadShotNews
2
9
20
2,471
JM Bryant, MD retweeted
🧬Urinary extracellular vesicle miRNAs to detect pancreatic cancer @eClinicalMed ✅Sensitivity (training and test sets) All: 93.9% and 77.8% Stage I/IIA: 97% and 77.8% ✅Outperformed ca19-9 ⁉️A noninvasive urinary assay 👉doi.org/10.1016/j.eclinm.202… @TheLancetOncol @TheLancet @OncoAlert @Aiims1742 #cancer #oncology #MedX
1
16
37
3,372
JM Bryant, MD retweeted
Dr Eric Tseng from @Sunnybrook @UofTDRO presenting the UNITED trial @mr_linac meeting in Singapore. Radiation exposure to normal brain can be minimized without compromising control for glioblastoma using online adaptive radiotherapy on the MR-Linac
1
8
34
2,127
Congratulations to @JacqAndreozzi on winning the ARRO educator of the year award, @NakashimaJustyn on winning the clinical award, and to @JMBryantMD on winning the leadership award! 💪🏽💥@JessicaFrakesMD @SA_Rosenberg
4
22
902
Moffitt study presented at #ASTRO24 shows promising results for treating aggressive prostate cancer with #immunotherapy. #MoffittASTRO24 @ASTRO_org @JMBryantMD bit.ly/3Y4QSym
2
5
691
The team having fun and sharing their work at #ASTRO24 @MoffittNews @ASTRO_org 💪🏽🧬
1
4
1
23
1,464